Pay in 4 interest-free payments of $3.75 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
(AURC) Liquidity
(HPK) Annual Income Statement
(LAZR) Annual Income Statement
[leftmenu] Evergy
[leftmenu] Paramount Gold Nevada Corp
Yifan Pharmaceutical Co., Ltd. (002019.SZ) Company Profile DCF ANALYSIS (AURC) Liquidity[leftmenu] Yifan Pharmaceutical Co., Ltd. (002019. SZ) Company Profile [header] [overview] Yifan Pharmaceutical Co., Ltd. (002019. SZ) Annual Income Statement, Cash Flow and Balance Sheet Yifan Pharmaceutical Co., Ltd. (002019. SZ) Liquidity, Profitability, Debt, Operating Performance, Cash Flow, Valuation Ratios [profile]
US$ 447.50
US$ 547.50
US$ 105.00
US$ 297.50
US$ 125.00
US$ 247.50
US$ 397.50
US$ 175.00
US$ 397.50
US$ 242.50
